Trial record 2 of 13 for:
krystal biotech
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04917874 |
Recruitment Status :
Completed
First Posted : June 8, 2021
Last Update Posted : April 9, 2024
|
Sponsor:
Krystal Biotech, Inc.
Information provided by (Responsible Party):
Krystal Biotech, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 31, 2023 |
Actual Study Completion Date : | July 31, 2023 |